About PPTA

The Plasma Protein Therapeutics Association is a 501(c)(6) non-profit trade association that represents plasma donation centers as well as plasma protein therapy manufacturers. Our mission is to promote the availability of and access to safe and effective plasma protein therapeutics for all patients in the world.

As a trusted partner to health systems, PPTA drives broad and reliable access to high-quality plasma protein therapies, with a focus on the well-being of patients and plasma donors. We will strive to achieve our mission by:

  • Fostering the collection of high-quality plasma from healthy donors;
  • Establishing standards for the manufacturing of lifesaving plasma protein therapies at the highest levels of safety and quality;
  • Breaking down artificial barriers on trade and compensated donors that limit patient access to therapy;
  • Supporting government reimbursement practices that reflect the unique nature of plasma protein therapies;
  • Educating all stakeholders about the value of the therapies; and
  • Adhering to the PPTA Code of Ethics.

For more information, please visit:

Standards & Programs

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

  • International Quality Plasma Program (IQPP)

  • Quality Standards of Excellence, Assurance and Leadership (QSEAL)

  • National Donor Deferral Registry (NDDR)

  • Patient Notification System (PNS)

  • North America Data Program

PPTA Source Members in North America

  • ABO Plasma

  • Access Plasma LLC

  • ADMA BioCenters

  • B Positive Plasma LLC
  • BioLife Plasma Services LP/Takeda
  • Biomat USA/Grifols

  • BPL Plasma Inc.
  • Canadian Plasma Resources
  • Freedom Plasma/BioTek America

  • Hemarus LLC

  • Immunotek Bio Centers LLC
  • Kamada Plasma


  • Octapharma Plasma
  • ProMetic Plasma Resources
  • Scantibodies Biologics
  • Southern Blood Services

PPTA North America Members

Copyright © 2023 PPTA | Privacy Statement